Back to Companies
Lineage Cell Therapeutics, Inc.
LCTXNYSECIK: 0000876343
Over the 13 most recent insider filings, Lineage Cell Therapeutics, Inc. (LCTX) has seen activity from 9 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $895.4K bought versus $0 sold, a net purchase of $895.4K. BROADWOOD PARTNERS, L.P. (Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $770.7K by BROADWOOD PARTNERS, L.P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.7M
Purchases
$895.4K
Sales
$0
Unique Insiders
9
Recent Insider Trades
13 loaded
| Nov 19 | LCTX Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS, L.P. | Director, 10% Owner | Buy | $770.7K |
| Nov 19 | LCTX Lineage Cell Therapeutics, Inc. | Mulroy Michael H. | Director | Buy | $26.1K |
| Nov 17 | LCTX Lineage Cell Therapeutics, Inc. | Culley Brian M | Insider | Buy | $37.1K |
| Nov 16 | LCTX Lineage Cell Therapeutics, Inc. | Howe Jill Ann | Insider | Buy | $17.1K |
| Nov 17 | LCTX Lineage Cell Therapeutics, Inc. | ANDREWS DEBORAH J | Insider | Buy | $20.0K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Russell Angus C. | Insider | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Bradsher Neal C | Director, 10% Owner | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Jayasuriya Anula | Insider | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | ANDREWS DEBORAH J | Insider | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Mulroy Michael H. | Insider | Award | $162.5K |
| Mar 12 | LCTX Lineage Cell Therapeutics, Inc. | Culley Brian M | Insider | Buy | $24.4K |
| Dec 19 | LCTX Lineage Cell Therapeutics, Inc. | Samuel George A. III | Insider | Grant | $109 |
| Dec 19 | LCTX Lineage Cell Therapeutics, Inc. | Culley Brian M | Insider | Grant | $561 |
13 filings